Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on May 5, 2022. The filing serves to announce the Company's financial results for the period ended March 31, 2022, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates an update on recent corporate events alongside the Q1 2022 financial results. Specific details regarding material changes versus the prior comparable period are not present in the cover page text.
Guidance, Outlook, and Risks
Management commentary, guidance, and outlook are contained within the furnished press release and letter to stockholders. The filing explicitly states that the information furnished under Item 2.02 is not deemed "filed" for purposes of Section 18 of the Exchange Act and does not constitute an admission of material information under Regulation FD. The Company does not assume an obligation to update this information in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q1 2022 revenue and earnings figures.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and strategic updates.
- Verify the status of the 8.625% Senior Notes due 2026 (HROWL) listed as registered securities.
- Confirm if the "recent corporate events" mentioned involve material changes to operations or capital structure.